Canada November retail gross sales flat; seen up 1.6% in December

1 month ago

Jan 23 (Reuters) - Canadian retail gross sales had been unchanged in November from October at C$67.57 billion ($46.99 billion),…

exp World Holdings CEO Glenn Darrel Sanford sells $285,905 in inventory

1 month ago

BELLINGHAM, WA—Glenn Darrel Sanford, the CEO and Chairman of the Board of eXp World Holdings, Inc. (NASDAQ:EXPI), a $1.75 billion…

Texas Capital Bancshares inventory plunges 25% after This fall outcomes

1 month ago

DALLAS - Texas Capital Bancshares, Inc. (NASDAQ:TCBI) reported fourth quarter earnings that exceeded analyst expectations. The inventory fell practically 25%…

Replimune’s SWOT evaluation: oncolytic immunotherapy inventory faces pivotal yr

1 month ago

Replimune Group Inc (NASDAQ:REPL), a biotechnology firm specializing in oncolytic immunotherapy for most cancers remedy, stands at a vital juncture…

What does UK’s Reeves’ elimination of a contest regulator imply for progress?

1 month ago

LONDON (Reuters) - British finance minister Rachel Reeves has pressured out the chairman of the nation's competitors watchdog, saying he…

Alaska Air beats This autumn revenue estimates, sees smaller Q1 loss on sturdy journey demand

1 month ago

By Rajesh Kumar Singh and Aatreyee Dasgupta (Reuters) - Alaska Air (NYSE:ALK) Group on Wednesday topped Wall Avenue estimates for…

Nibiru EVM (Nibiru V2) Codebase Finalized Following Rigorous Safety Audits

1 month ago

Tortola, British Virgin Islands, January twenty third, 2025, Chainwire Nibiru, a safe and high-performance blockchain, has reached profitable code completion…

Joby Aviation president of operations sells shares value $262,303

1 month ago

Bonny Simi, President of Operations at Joby Aviation , Inc. (NYSE:JOBY), not too long ago offered 31,489 shares of the…

Banc of California shares rise practically 3% on This autumn earnings beat

1 month ago

LOS ANGELES - Banc of California , Inc. (NYSE: NYSE:BANC) reported fourth quarter earnings that beat analyst estimates, sending shares…

Revolution Medicines’ SWOT evaluation: inventory poised for development amid scientific trials

1 month ago

Revolution Medicines, Inc. (NASDAQ:RVMD), a biotechnology firm targeted on creating novel therapies for RAS-dependent cancers, has been garnering important consideration…